SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SI-BONE, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$19.66−0.02 (-0.10%)
Close on Oct 19, 2026
- Market cap
- $874.42M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
SI-BONE, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $53.23M | $49.30M | $53.45M | $46.37M | $46.43M | $44.84M | $46.91M | $38.26M | $37.81M | $35.43M | $36.65M | $32.30M | 95.0% | +14.7% |
| International | $2.78M | $3.29M | $2.90M | $2.29M | $2.21M | $2.45M | $2.09M | $2.08M | $2.16M | $2.44M | $2.21M | $1.71M | 5.0% | +25.9% |
From the segment and revenue-disaggregation notes of Si-Bone's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.